Idenix Pharmaceuticals To Present at 12th Annual BIO CEO & Investor Conference
CAMBRIDGE, Mass., Feb. 1 Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the upcoming 12th Annual BIO CEO & Investor Conference on Monday, February 8, 2010 at 9:30 a.m. ET at the Waldorf-Astoria Hotel in New York, NY.
The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus. For further information about Idenix, please refer to http://www.idenix.com.
Idenix Pharmaceuticals Contact: Teri Dahlman (617) 995-9905
SOURCE Idenix Pharmaceuticals, Inc.
You May Also Like